Journal article · Vestibular← The news desk

✦ The Dispatch

Analysis of clinical efficacy of repetitive transcranial magnetic stimulation in the treatment of residual dizziness after reduction of benign paroxysmal positional vertigo

A dispatch from PubMed — filed

Clinical Takeaway

rTMS shows potential for residual dizziness post-BPPV canalith repositioning, but findings should be considered preliminary; audiologists and vestibular specialists should await replication in larger RCTs before adopting this into practice.

Why It Matters

Residual dizziness after BPPV repositioning is a common, poorly-addressed clinical problem, and if rTMS proves effective it could expand neuromodulation into vestibular rehabilitation.

Key Points
  1. 01Residual dizziness following successful BPPV canalith repositioning affects a significant subset of patients.
  2. 02rTMS (repetitive transcranial magnetic stimulation) was evaluated as a non-pharmacological intervention for this symptom.
  3. 03Published in European Archives of Otorhinolaryngology (PMID 42062570).
  4. 04Findings may inform future vestibular neuromodulation protocols if replicated.
  5. 05Evidence level and sample size details require full-text review to confirm.
Claims & Evidence

rTMS is clinically efficacious for treating residual dizziness after BPPV canalith repositioning.

studypartially supported
Research metadata
PMID
42062570
DOI
10.1007/s00405-026-10198-9.
Journal
European Archives of Oto-Rhino-Laryngology
Publication type
research_article
Evidence level
2b
Population
Patients with residual dizziness following successful BPPV canalith repositioning procedures
Intervention
Repetitive transcranial magnetic stimulation (rTMS)

Primary outcomes

Clinical efficacy of rTMS on residual dizziness severity; Symptom reduction after rTMS treatment

Related stories